|
New data from Boehringer Ingelheim and Pfizer's tiotropium clinical studies on …
News-Medical.net New data to be presented at the Annual Congress of the European Respiratory Society (ERS 2012), in Vienna, Austria, will shed light on the current and potential future role of tiotropium, the first once-daily long-acting inhaled anticholinergic for … BOEHRINGER INGELHEIM GMBH : Key results from new tiotropium studies in … |
View full post on asthma – Google News